Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Anastasia, Banti"'
Autor:
Eleni Gavriilaki, Evdoxia Koravou, Sotiria Dimou-Mpesikli, Emmanouil Nikolousis, Anastasia Banti, Charalampos Pontikoglou, Christina Kalpadakis, Aikaterini Bitsani, Iliana Tassi, Tasoula Touloumenidou, Thomas Chatzikonstantinou, Maria Papathanassiou, Antonia Syrigou, Eleutheria Ztriva, Georgia Kaiafa, Eudokia Mandala, Zois Mellios, Dimitrios Karakasis, Alexandra Kourakli, Argyris Symeonidis, Eleni Kapsali, Eleni Papadaki, Chrysavgi Lalayanni, Ioanna Sakellari
Publikováno v:
Blood. 140:8503-8504
Autor:
Antigoni Mamara, Anastasios E. Germenis, Maria Kompoti, Maria Palassopoulou, Eudokia Mandala, Anastasia Banti, Nikolaos Giannakoulas, Matthaios Speletas
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
TACI is a membrane receptor of BAFF and APRIL, contributing to the differentiation and survival of normal B cells. Although malignant B cells are also subjected on TACI signaling, there is a remarkable intradisease and interindividual variability of
Externí odkaz:
https://doaj.org/article/2d81c357973247b6aede21beb4809189
Autor:
Pavlina Konstantinidou, Maria K. Angelopoulou, Maria Arapaki, Chryssa Vadikolia, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Anastasia Banti, Emmanouil Spanoudakis, Maria Bouzani, Kostas Konstantopoulos, Theodoros Iliakis, Anastasia Sioni, Niki Stavroyianni, Eleftheria Hatzimichael, Vassiliki Pappa, Panayiotis Panayiotidis, Christina Kalpadakis, Sotirios Sachanas, Stavroula Giannouli, Sotirios G. Papageorgiou, Marie-Christine Kyrtsonis, Sofia Chatzileontiadou, Maria Tsirogianni, Marina P. Siakantaris, Evdokia Mandala, Christos Poziopoulos, Eugenia Verrou, Vasiliki Violaki, Elissavet Vervessou, Theodoros Marinakis, Maria Ximeri, Eirini Katodritou, Maria Dalekou-Tsolakou, Despoina Mparmparousi, Maria Dimou
Publikováno v:
Hematological oncologyREFERENCES. 39(3)
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gain
Autor:
Elissavet Vervessou, Evdokia Mandala, Maria Arapaki, Emmanouil Spanoudakis, Niki Stavroyianni, Vassiliki Pappa, Eirini Katodritou, Maria Dimou, Theodoros Iliakis, Theodoros P. Vassilakopoulos, Anastasia Sioni, Despoina Mparmparousi, Panayiotis Panayiotidis, Theodoros Marinakis, Maria Dalekou-Tsolakou, Maria K. Angelopoulou, Chryssa Vadikolia, Pavlina Konstantinidou, Kostas Konstantopoulos, Eleftheria Hatzimichael, Vasiliki Violaki, Pantelis Tsirkinidis, Sofia Chatzileontiadou, Marina P. Siakantaris, Christina Kalpadakis, Anastasia Banti, Maria Bouzani, Maria Ximeri, Christos Poziopoulos, Eugenia Verrou, Sotirios G. Papageorgiou, Marie-Christine Kyrtsonis, Stavroula Giannouli, Maria Tsirogianni, Sotirios Sachanas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dfebb9f038633f5741115c75c71a70e
https://doi.org/10.1002/hon.2842/v2/response1
https://doi.org/10.1002/hon.2842/v2/response1
Publikováno v:
The Israel Medical Association journal : IMAJ. 18(9)
Antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by vascular thrombosis (arterial or venous) and/or pregnancy complications associated with the occurrence of autoantibodies, specifically lupus anticoagulant, anticardiol
Autor:
Matthaios Speletas, Smaragda Effraimidou, Dimitrios Kapetanos, Evgenia Verrou, Anastasia Banti, Charalambos Kartsios, Eirini Katodritou, Evangelos Terpos, John Christakis, Konstantinos Zervas
Publikováno v:
Annals of Hematology. 86:369-376
The aim of the study was to evaluate the role of hypochromic erythrocytes (HYPO%) compared to “traditional” and novel markers of iron status and erythropoiesis in recognizing iron-restricted erythropoiesis (IRE) and predicting response to erythro
Autor:
Maria Kompoti, Anastasios E. Germenis, Maria Palassopoulou, Antigoni Mamara, Eudokia Mandala, Matthaios Speletas, Anastasia Banti, Nikolaos Giannakoulas
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2015 (2015)
Journal of Immunology Research, Vol 2015 (2015)
TACI is a membrane receptor of BAFF and APRIL, contributing to the differentiation and survival of normal B cells. Although malignant B cells are also subjected on TACI signaling, there is a remarkable intradisease and interindividual variability of
Autor:
Taxiarchis Kourelis, Nikolaos Harhalakis, Vassilios Papadopoulos, Maria Palasopoulou, Nora-Athina Viniou, George Vassilopoulos, George Karavalakis, D.S. Kyriakou, Diamantina Vasilatou, Evdoxia Hatjiharissi, Eleftheria Hatzimichael, Alexandra Kourakli, Theodoros Marinakis, Anastasia Banti, Chara Giatra, Emmanuel Papadakis, Polyxeni Lampropoulou, Panayiotis Panayiotidis, Damianos Sotiropoulos, Argiris Symeonidis, George Papaioannou, Maria Dimou, Panagiotis Repousis, Achilles Anagnostopoulos
Publikováno v:
Blood. 128:5476-5476
BACKGROUND - AIM Ruxolitinib can be effectively used for the treatment of splenomegaly or constitutional symptoms in patients with myelofibrosis. Its main side effect is myelosuppression which leads to dose modifications. Real-life data from the use
Autor:
Charalambos Kartsios, Evgenia Verrou, Dimitra Mihou, Vassiliki Kaloutsi, Anastasia Banti, Eirini Katodritou, Anna Lazaridou, Vassiliki Gastari, Georgia Lazaraki, Konstantinos Zervas
Publikováno v:
Leukemia Research. 32:339-341
We report a case of a 68-year-old man presented with upper-gastrointestinal bleeding. Endoscopy showed a large ulcerated gastric mass. Histological examination of the gastric biopsies revealed a k monoclonal extramedullary plasmacytoma (EMP). Further
Autor:
George Vassilopoulos, Eleftheria Hatzimichael, Vassilios Papadopoulos, Panayiotis Panayiotidis, Maria Dimou, Emmanuel Papadakis, George Papaioannou, Theodoros Marinakis, Nora-Athina Viniou, D.S. Kyriakou, Achilles Anagnostopoulos, Maria Palasopoulou, Diamantina Vasilatou, Taxiarchis Kourelis, Alexandra Kouraklis, Damianos Sotiropoulos, George Karavalakis, Anastasia Banti
Publikováno v:
Blood. 126:5192-5192
PATIENTS AND METHODS A multicenter observational study was conducted in patients with myelofibrosis receiving ruxolitinib. Data regarding disease characteristics, dosage, safety and efficacy of ruxolitinib were collected retrospectively. A total of 7